From January 1, 2024 to March 22, 2024, the company has repurchased 0 shares, representing 0% for ¥0 million. With this, the company has completed the repurchase of 12,571,400 shares, representing 3.38% for ¥16,178.35 million under the buyback announced on May 11, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,635 JPY | +0.93% | -0.21% | +16.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.41% | 3.71B | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+18.87% | 249B | |
-1.96% | 216B | |
+11.11% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.